⚠️

Important: VAERS reports alone cannot determine if a vaccine caused an adverse event. Reports may contain incomplete, inaccurate, or unverified information. Correlation does not equal causation.

Zoster Live (Zostavax)2017

Zoster Live (Zostavax) in 2017

3,900 adverse event reports (-4% vs 2016)

Share
3,900
Reports
18
Deaths
53
Hospitalizations
414
ER Visits
73
Disabilities

2017 Reporting Summary

In 2017, 3,900 adverse event reports were filed for Zoster Live (Zostavax) in VAERS. This represents 2.8% of all 140,312 reports for this vaccine.

Of these reports, 18 mentioned death, 53 involved hospitalization, 414 required ER visits, and 73 reported disability.

Compared to the average of 6,673 reports per year for this vaccine, 2017 was below average (-42%).

💡 What This Means

In 2017, reporting for Zoster Live (Zostavax) was within typical ranges. As always, VAERS data reflects reports filed, not confirmed adverse events. Trends should be interpreted alongside vaccination volume and population health data.

All Years for Zoster Live (Zostavax)

YearReportsDeathsHosp.
20256,46823128
20246,29819159
20238,90826211
20229,54445207
202114,53852259
202013,06619709
201918,93035790
201819,13332910
2017 ← current3,9001853
20164,0821067
20154,455674
20144,9579112
20135,30915119
20124,01312105
20112,165361
20109731046
20091,9621679
20082,2811077
20072,2871390
200619104

Understanding Yearly Data

Spikes may reflect awareness: Years with unusual activity (e.g., pandemic) often see increased reporting.
Dose volume matters: More vaccinations given in a year naturally leads to more reports.
Reporting lag: Some events are reported months after they occur, so recent years may be incomplete.

Quick Facts

Reports:3,900
Deaths:18
Hospitalizations:53
% of Total:2.8%
Rank (by vol.):#14 of 20 years
Avg/year:6,673

Data Source

This data comes from the Vaccine Adverse Event Reporting System (VAERS), jointly managed by CDC and FDA.